141 related articles for article (PubMed ID: 9520576)
1. [Prevention of osteoporosis-related fractures with alendronate].
Kopjar B; Bjørndal A
Tidsskr Nor Laegeforen; 1998 Feb; 118(4):518-9. PubMed ID: 9520576
[No Abstract] [Full Text] [Related]
2. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
4. Do not use bisphosphonate therapy indefinitely for fracture prevention.
Prescrire Int; 2008 Oct; 17(97):214. PubMed ID: 19536944
[TBL] [Abstract][Full Text] [Related]
5. Preventing osteoporotic fractures with alendronate.
Maughan KL
J Fam Pract; 1997 Apr; 44(4):336. PubMed ID: 9148031
[No Abstract] [Full Text] [Related]
6. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
7. [Working title: Will reducing alendronate increase the risk of bone fractures by a decrease in bone density? Benefit from alendronate therapy for women without prior fractures remains uncertain].
Ritzmann P
Praxis (Bern 1994); 1999 Sep; 88(40):1631-2. PubMed ID: 10536501
[No Abstract] [Full Text] [Related]
8. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
Bize R; Lamy O; Peytremann-Bridevaux I
Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
[No Abstract] [Full Text] [Related]
9. The treatment of postmenopausal osteoporosis.
Sambrook PN
N Engl J Med; 1995 Nov; 333(22):1495-6. PubMed ID: 7477151
[No Abstract] [Full Text] [Related]
10. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
11. Alendronate in postmenopausal osteoporosis.
McGrath H
N Engl J Med; 1996 Mar; 334(11):734; author reply 734-5. PubMed ID: 8594443
[No Abstract] [Full Text] [Related]
12. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
Lufkin EG; Sarkar S; Kulkarni PM; Ciaccia AV; Siddhanti S; Stock J; Plouffe L
Curr Med Res Opin; 2004 Mar; 20(3):351-7. PubMed ID: 15025844
[TBL] [Abstract][Full Text] [Related]
13. Decimal point--osteoporosis therapy at the 10-year mark.
Strewler GJ
N Engl J Med; 2004 Mar; 350(12):1172-4. PubMed ID: 15028820
[No Abstract] [Full Text] [Related]
14. [Alendronate (Fosamax 10 mg). The first amino-biphosphate for the treatment of women with postmenopausal osteoporosis].
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10 Suppl):1-4. PubMed ID: 9022376
[No Abstract] [Full Text] [Related]
15. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
[TBL] [Abstract][Full Text] [Related]
16. Alendronate: a new bisphosphonate for the treatment of osteoporosis.
Keen RW; Spector TD
Br J Clin Pract; 1996 Jun; 50(4):211-7. PubMed ID: 8759568
[TBL] [Abstract][Full Text] [Related]
17. Drugs for prevention and treatment of postmenopausal osteoporosis.
Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651
[No Abstract] [Full Text] [Related]
18. Osteoporosis prevention and treatment.
Burger HG
Med J Aust; 2000 Aug; 173(3):167-8. PubMed ID: 10979391
[No Abstract] [Full Text] [Related]
19. Renal function and bisphosphonate safety.
Ott SM; Drueke T; Elder G; Fukagawa M; Jorgetti V; Langman CB; Moe S; McCann L; Wang AY; Weisinger J; Wheeler D
J Bone Miner Res; 2008 Mar; 23(3):453-4; author reply 455. PubMed ID: 17967135
[No Abstract] [Full Text] [Related]
20. [Calcium gaps in osteoporosis patients close. Blister pack simplifies comedication of calcium and bisphosphonates].
MMW Fortschr Med; 2005 Apr; 147(14):44. PubMed ID: 15887685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
